Development of De Novo Donor Specific Antibodies Following COVID-19 Vaccination in Cardiac Transplant

PURPOSE: Some transplant patients mount an insufficient response to standard COVID-19 vaccine (COVAX) dosing and a booster dose has now been approved. Vaccination carries the theoretical risk of stimulating antibody production to the donor. There are no prior studies surveying de novo donor specific...

Descripción completa

Detalles Bibliográficos
Autores principales: Maybaum, S., Rahman, A., Malhame, K., Rossi, D., Wallach, F., Kon, Z., Stevens, G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2022
Materias:
(782)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988555/
http://dx.doi.org/10.1016/j.healun.2022.01.803

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988555/
http://dx.doi.org/10.1016/j.healun.2022.01.803

Ejemplares similares